Applications of 5-Bromouracil in Industrial Manufacturing

As a specialist manufacturer of 5-Bromouracil, we provide high-purity input for advanced industrial applications across the global chemical and life sciences sectors. Below are detailed application scenarios where our product delivers consistent performance, meets stringent industry standards, and integrates efficiently into downstream processing lines.

1. DNA Mutagenesis for Genetic Research and Diagnostic Tool Development

5-Bromouracil acts as a thymine analog in genetic engineering, enabling precise incorporation into DNA to induce point mutations. This property is crucial for laboratories developing diagnostic probes, functional genomics assays, and creating mutant strains for biotechnology research. Large-scale synthesis facilities rely on stable, high-purity input to maintain reproducibility and regulatory traceability throughout the process.

Industry compliance standards

• ISO 9001:2015 (Quality Management Systems for chemical synthesis)
• OECD Good Laboratory Practice (GLP) Guidelines
• US Pharmacopeia (USP) Reference Standards for molecular biology reagents
• Chemical safety documentation as per REACH (EC 1907/2006)

Typical usage ratio

• Generally incorporated at 0.1–1.5 mmol/L in DNA polymerization reactions, adjusted based on assay sensitivity and desired mutagenesis rate

Downstream process integration

• Added during in vitro nucleotide incorporation stages, typically using automated DNA synthesizers or enzymatic reaction setups

Final product types

• Mutant DNA libraries for research use
• Gene-editing probe kits
• Molecular diagnostic platform reagents
• Modified organism seed stocks

2. Nucleic Acid Pharmaceutical Intermediate Synthesis

In pharmaceutical manufacturing, 5-Bromouracil is essential for synthesizing antivirals and nucleoside analog intermediates. AP Iproduction sites and contract research organizations consistently source this compound to build complex active pharmaceutical ingredient structures where halogenated uracil rings play a functional role. Tight process control and material traceability are required at every stage.

Industry compliance standards

• ICH Q7 (Good Manufacturing Practice for Active Pharmaceutical Ingredients)
• 21 CFR Part 210/211 (US FDA cGMP for drugs)
• European Pharmacopoeia monographs (Ph. Eur.)
• Drug Master File (DMF) submission requirements in regulated markets

Typical usage ratio

• Functionalized typically at 2–8% molar ratio relative to total uracil compounds in batch production, adjusted according to target molecule design

Downstream process integration

• Introduced during early-stage condensation or coupling reactions in small molecule synthesis and polymer-supported nucleotide assembly lines

Final product types

• Antiviral nucleotide prodrugs (e.g., for research and trial batches)
• Nucleoside analog intermediate compounds
• Halogenated nucleobase pharmaceuticals

3. Radiolabeling Reagents for Biochemical Assay Kits

This compound’s brominated structure makes it suitable for specific radioisotope exchange reactions, producing radiolabeled tracers used in high-sensitivity biochemical assays, including PCR quantification kits and binding affinity test platforms. Controlled handling is paramount in radiochemistry, emphasizing purity, stability, and compliance with isotopic safety regulations.

Industry compliance standards

• ISO 13485:2016 (Quality Management for medical device components, including diagnostic reagents)
• IAEA Code of Conduct for Radioisotope Production
• U.S. NRC 10 CFR Part 20 (Radiological Health and Safety)
• CLSI EP17 guidelines for assay validation

Typical usage ratio

• Typically 0.2–0.5 mmol/L for in vitro radiolabeling, adjusted according to specific activity targets and detection limits

Downstream process integration

• Subjected to halogen exchange reactions, incorporation occurs during final labeling steps before downstream kit assembly or reagent blending

Final product types

• Radiolabeled DNA synthesis kits
• Affinity chromatography reference standards
• Molecular imaging reagents for laboratory research

4. Photoreactive Crosslinking Agent for DNA-Protein Interaction Studies

Research labs and industrial biological suppliers employ 5-Bromouracil in crosslinking protocols to study interactions between nucleic acids and proteins. Upon UV irradiation, the brominated nucleobase facilitates covalent bond formation, allowing downstream mapping of DNA-binding protein sites. Quality specification consistency ensures accurate, reproducible results across large reagent lots.

Industry compliance standards

• ISO 17025:2017 (Testing laboratory accreditation)
• EU Chemicals Regulation (EC) No 1272/2008 on classification, labeling, and packaging)
• Material compatibility reviews as per ANSI standards for laboratory bioreagents
• REACH Annex VII toxicological risk assessment

Typical usage ratio

• Prepared at 0.05–0.5 mmol/L in DNA substrates, with precise control based on nucleic acid length and irradiation protocol parameters

Downstream process integration

• Incorporated during oligonucleotide synthesis or enzymatic reactions, followed by UV crosslinking in dedicated biological containment systems

Final product types

• DNA-protein crosslinking reagent kits
• Structural biology research reagents
• Chromatin immunoprecipitation (ChIP) workflow kits

5. Mutagenesis Standards for Environmental and Food Safety Testing

Regulatory laboratories utilize 5-Bromouracil as a positive control for validating mutagenicity test protocols such as the Ames test. These applications demand strictly defined purity levels and traceable supply chains to ensure accurate quantification of genotoxic potential in environmental, food, and veterinary product testing under international guidelines.

Industry compliance standards

• OECD Test Guideline 471 (Bacterial Reverse Mutation Test/Ames Test)
• ISO 17034:2016 (Reference material producer accreditation)
• GLP compliance in environmental and food testing labs
• US EPA guidelines for toxicity screening

Typical usage ratio

• Used at defined concentrations, typically 1–20 μg per assay plate depending on strain susceptibility and test design

Downstream process integration

• Dosed directly into bacterial culture media at assay setup phase, tracked through validated workflow protocols

Final product types

• GRAS assessment kits for food safety labs
• Environmental genotoxicity reference panels
• Mutagenicity assay control substance vials